Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery

NCT00459108 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

25

Enrollment

NIH

Sponsor class

Stopped Halted early for futility.

Conditions

Adult Primary Hepatocellular Carcinoma
Advanced Adult Primary Liver Cancer
Recurrent Adult Primary Liver Cancer

Interventions

DRUG: dasatinib

Sponsor

National Cancer Institute (NCI)